MASH is a progressive liver disease characterised by inflammation and fibrosis and is closely linked to obesity and Type 2 diabetes
Prescriptions must be issued by a primary care physician or licensed medical doctor practicing within the USA only
A Twin provider determines clinical eligibility before the first prescription, and monitors each member's real-time metabolic data throughout to adjust dosing, build habits that outlast the medication, and initiate structured tapering when clinical signals indicate the member is ready
Key steps include leucine binding to the Sestrin2 protein, relieving its inhibition of the GATOR2 complex, subsequently promoting Rag GTPase complex activation, and ultimately recruiting mTORC1 to the lysosomal surface for activation by the Rheb protein (25, 26)
Initial studies indicate that retatrutide might assist in adult weight reduction, but its application post pregnancy remains under examination